Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors

NEXT STORY
Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
PREV STORY
Virtual Clinical Trials APAC Industry to 2026 – Featuring Dassault Systemes, Oracle and PRA Health Sciences Among Others
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NorthStar Moving Announces Partnership with YogaWorks

LOS ANGELES, March 23, 2016 (GLOBE NEWSWIRE) -- NorthStar Moving ® Company, the leading ...

author_avatar
NASDAQ Market News

Global Task Trainers Market Outlook: 2017-2022 – Laerdal Medical is the leader in the global task trainers market with the strong distribution channel

Dublin, May 12, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News

Crizotinib Demonstrates Clinical Benefit in Phase II Study of East Asian Patients with ROS1-Positive Non-Small Cell Lung Cancer

CHICAGO, June 03, 2016 (GLOBE NEWSWIRE) -- OxOnc Development LP, (OxOnc), today announced that ...

author_avatar
NASDAQ Market News